The Valens Company Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VLNS research report →
Price Chart
About the company
The Valens Company Inc. is a Canadian-headquartered enterprise with international reach, focused on the development, manufacturing, and sale of cannabinoid-based products. Its product portfolio encompasses dried cannabis and hemp biomass, alongside a wide array of consumer goods such as tinctures, two-piece caps, soft gels, oral sprays, vape pens, beverages, diverse concentrates, topicals, edibles, and natural health products.
- CEO
- Jeffrey Fallows CFA
- IPO
- 2009
- Employees
- 445
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on VLNS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $61.46M
- P/E
- -0.88
- PEG
- 0.01
- P/S
- 0.00
- P/B
- 0.17
- EV/EBITDA
- 0.02
- Div Yield
- 0.00%
- Gross Margin
- 22.05%
- Op Margin
- -69.06%
- Net Margin
- -62.72%
- ROE
- -25.35%
- ROIC
- -16.24%
- 52W High
- $3.00
- 52W Low
- $0.58
- 50D MA
- $0.78
- 200D MA
- $0.79
- Beta
- 0.00
- RSI (14)
- 54
- Avg Volume
- 120.95K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Valens said Q2 was below expectations, with provincial sales disrupted by a Verse-to-Versus rebrand, but June rebounded sharply and management expects cost savings, market share gains, and improved cash burn in the back half of the year.· July 14, 2022
- Consolidated net revenue rose 3.5% to $24 million, but provincial sales fell 14.8% to $9.2 million because of the rebrand transition and delayed shipments.
- Adjusted gross profit was $3.4 million, or 14% of net revenue; adjusted EBITDA was negative $15.9 million, improving to negative $14.4 million excluding a $1.4 million non-cash B2B receivable impairment.
- SG&A declined 6.2%, and management said integration actions had already identified $15 million of annual cost savings, with over $5 million more targeted.
- Canadian recreational market share increased from 2.8% to 3.2%; Green Roads revenue rose 11.8% to $5.7 million; B2B revenue rose 11.1% to $7 million.
- June was described as a record month with strong July purchase-order visibility, and management said the Coldhaus partnership and Quebec launch should help provincial sales in coming quarters.
Valens reported Q2 fiscal 2022 consolidated net revenue of $24 million, up 3.5% year over year. Provincial sales revenue was $9.2 million, down 14.8%, while B2B revenue was $7 million, up 11.1%, and Green Roads revenue was $5.7 million, up 11.8%. Adjusted gross profit was $3.4 million, or 14% of net revenue, and adjusted EBITDA was negative $15.9 million; excluding a $1.4 million non-cash impairment, adjusted EBITDA would have been negative $14.4 million versus negative $17.6 million in Q1. SG&A declined 6.2%, and cash flow from operations improved by $3.2 million quarter over quarter, with combined operating and investing cash flow improving $4.8 million. Looking ahead, management said Q3 cash burn from operations should improve to between negative $9 million and negative $12 million, and they expect to exceed the original $20 million annual cost-savings target by fiscal year-end 2022.
Tyler Robson framed the quarter as disappointing but fixable, emphasizing that the biggest issue was the temporary disruption from the Verse-to-Versus transition rather than demand weakness. He said the company is seeing the right fundamentals improve: June was a record month, provincial sales are back on track, and internal execution on SG&A and cash burn is moving in the right direction even if not fast enough. His tone was cautious but confident, with repeated emphasis that the business is improving and that Valens will bounce back.
Sunil Gandhi said the operating environment remains challenging because of inflation, supply-chain volatility, and retail price compression, and he expects 2022 to remain difficult across the industry. He highlighted the financial improvements already underway: $15 million of annual savings identified and actioned, another $5 million+ identified, SG&A down 6.2%, and a combined $4.8 million improvement in cash flow from operations and investing activities quarter over quarter. He also said Q3 operating cash burn should improve to between negative $9 million and negative $12 million, and that the company is exploring non-dilutive liquidity options such as operating lines or working capital solutions for flexibility.
Analysts pressed management on the size and duration of the Verse-to-Versus disruption, and Adam Shea said the issue likely cost one to two weeks of depletions, with major markets typically moving 800,000 to 1 million units a week. Questions also focused on gross margin and the path to EBITDA profitability; Sunil said management expects gross margin to “double” from current levels and eventually be north of 30%, while Jeff and Sunil said EBITDA improvement will come from revenue growth, the $20 million-plus in savings, and a better product mix. Another major topic was the Coldhaus partnership, which management said begins September 1 and will give Valens broader reach, weekly or bi-weekly store coverage in key provinces, and CRM-driven store-level intelligence.
The call pointed to real operating momentum beneath the headline revenue miss: market share rose to 3.2%, June sales were a record, and management said provincial sell-in and July order visibility are both strong. Valens also sees multiple levers for improvement—more than $20 million of cost savings, better gross margins from automation and sourcing, and growth from Coldhaus, Quebec, Green Roads, and B2B.
The quarter showed that execution issues can still materially hit revenue, especially when a brand transition is not properly handled by provincial distributors. Gross margin remains only 14%, adjusted EBITDA was deeply negative, and management admitted cash burn is still not improving fast enough. They also flagged ongoing industry pressure from inflation, supply chain volatility, retail price compression, and the risk of further financial failures across the cannabis market.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 0.0%
- Shares Outstanding
- 80.74M
- Float Shares
- 0
Our VLNS coverage
Recent articles, reports, and earnings notes.
No research on VLNS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VLNS report →Valens Semiconductor to Collaborate with onsemi on a Cost-Optimized Integrated Sensor Based on the MIPI A-PHY Standard
prnewswire.com · Sep 22
Valens Semiconductor Appoints Asaf Silberstein to its Board of Directors
prnewswire.com · Sep 14
Valens Semiconductor: Decent Q2, But Still A Long Road To Profitability
seekingalpha.com · Aug 14
Valens Semiconductor Q2 Earnings Call Highlights
marketbeat.com · Aug 12
Valens Semiconductor Reports Strong Second Quarter 2026 Results and Raises Full-Year Revenue Guidance
prnewswire.com · Aug 12
Valens Semiconductor Appoints Dean Martin to Lead the Automotive Business Unit
prnewswire.com · Jul 31
NYSE to Commence Delisting Proceedings with Respect to Warrants of Valens Semiconductor Ltd. (VLNW)
businesswire.com · Jul 24
Valens Sets Second Quarter 2026 Conference Call for Wednesday, August 12 at 8:30 a.m. ET, 2026
prnewswire.com · Jul 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.